Skip to Content


Dan Diamond, featuring blog post by Rachel Sachs (Academic Fellow alumna)
Politico Pulse
January 31, 2017

Read the full article

From the article:

Trump's order on regulations is a 'terrible idea' for rulemaking. That's according to law professor Rachel Sachs, who uses the 21st Century Cures Act — which passed Congress with bipartisan support — as an example of how Trump's order could backfire.

"The 'regulations' the FDA would issue under the Act — whether through notice-and-comment rulemaking or guidance — are not ones the agency in its own judgment has decided are necessary," Sachs writes at Harvard's "Bill of Health" blog. "Yet for every one of these new 'regulations,' this EO will require the agency to remove two prior regulations? This is a terrible idea."

Read more of the article here! Read the Rachel Sach's blog post here!

Read the full article

Tags

bioethics   fda   health law policy   international   pharmaceuticals   rachel sachs   regulation